These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 5411180)

  • 1. Bladder cancer induction by aromatic amines: role of N-hydroxy metabolites.
    Radomski JL; Brill E
    Science; 1970 Feb; 167(3920):992-3. PubMed ID: 5411180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of N-oxidation products of aromatic amines in the induction of baldder cancer in the dog.
    Radomski JL; Brill E
    Arch Toxikol; 1971; 28(3):159-75. PubMed ID: 5126459
    [No Abstract]   [Full Text] [Related]  

  • 3. N-Glucuronidation of N-hydroxy aromatic amines: a mechanism for their transport and bladder-specific carcinogenicity.
    Poupko JM; Hearn WL; Radomski JL
    Toxicol Appl Pharmacol; 1979 Sep; 50(3):479-84. PubMed ID: 516060
    [No Abstract]   [Full Text] [Related]  

  • 4. Organ, species, and compound specificity in the metabolic activation of primary aromatic amines.
    Poupko JM; Radomski T; Santella RM; Radomski JL
    J Natl Cancer Inst; 1983 Jun; 70(6):1077-80. PubMed ID: 6574277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of dog bladder mucosa in the N-oxidation of arylamines.
    Brill E
    Res Commun Chem Pathol Pharmacol; 1977 Jan; 16(1):73-84. PubMed ID: 841183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The metabolism of aromatic amines.
    Gorrod JW; Manson D
    Xenobiotica; 1986; 16(10-11):933-55. PubMed ID: 3541401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic activation of aromatic amines and azo dyes.
    Bartsch H
    IARC Sci Publ; 1981; (40):13-30. PubMed ID: 6799396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinogenicity testing of N-hydroxy and other oxidation and decomposition products of 1- and 2-naphthylamine.
    Radomski JL; Brill E; Deichmann WB; Glass EM
    Cancer Res; 1971 Oct; 31(10):1461-7. PubMed ID: 4328736
    [No Abstract]   [Full Text] [Related]  

  • 9. Arylamine-DNA adducts in vitro and in vivo: their role in bacterial mutagenesis and urinary bladder carcinogenesis.
    Beland FA; Beranek DT; Dooley KL; Heflich RH; Kadlubar FF
    Environ Health Perspect; 1983 Mar; 49():125-34. PubMed ID: 6339219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cocarcinogenic interaction between D,L-tryptophan and 4-aminobiphenyl or 2-naphthylamine in dogs.
    Radomski JL; Radomski T; MacDonald WE
    J Natl Cancer Inst; 1977 Jun; 58(6):1831-4. PubMed ID: 864760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinogenicity and metabolism of aromatic amines in the dog.
    Deichmann WB; Radomski JL
    J Natl Cancer Inst; 1969 Jul; 43(1):263-9. PubMed ID: 4307704
    [No Abstract]   [Full Text] [Related]  

  • 12. Major urinary metabolites of 2-naphthylamine in dogs, monkeys, and mice.
    Conzelman GM; Flanders LE; Springer K; Crout DW
    Am J Vet Res; 1969 Dec; 30(12):2083-90. PubMed ID: 5353064
    [No Abstract]   [Full Text] [Related]  

  • 13. Occupational bladder cancer.
    Parkes HG
    Practitioner; 1975 Jan; 214(1279):80-6. PubMed ID: 1096114
    [No Abstract]   [Full Text] [Related]  

  • 14. Specific aromatic amines as occupational bladder carcinogens.
    Clayson DB
    Natl Cancer Inst Monogr; 1981 Dec; (58):15-9. PubMed ID: 7341971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the in vitro and in vivo N-oxidation of the carcinogenic aromatic amines.
    Brill E; Radomski JL
    Xenobiotica; 1971; 1(4):347-8. PubMed ID: 5164813
    [No Abstract]   [Full Text] [Related]  

  • 16. [N-hydroxylation of aromatic amines and their significance for development of bladder tumors].
    Uehleke H
    Arzneimittelforschung; 1969 Jul; 19(7):1033-9. PubMed ID: 4899291
    [No Abstract]   [Full Text] [Related]  

  • 17. Increased metabolic N-oxidation of 2-naphthylamine in dogs after phenobarbital pretreatment.
    Uehleke H; Brill E
    Biochem Pharmacol; 1968 Jul; 17(7):1459-61. PubMed ID: 5659788
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of ascorbic acid upon bladder uptake of -naphthylamine metabolites.
    Alam BS; Jaramillo FE; Schlegel JU; DeRouen TA
    Proc Soc Exp Biol Med; 1972 Dec; 141(3):1008-13. PubMed ID: 4645747
    [No Abstract]   [Full Text] [Related]  

  • 19. Formation and persistence of arylamine DNA adducts in vivo.
    Beland FA; Kadlubar FF
    Environ Health Perspect; 1985 Oct; 62():19-30. PubMed ID: 4085422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pharmacokinetic model to predict exposure of the bladder epithelium to urinary N-hydroxyarylamine carcinogens as a function of urine pH, voiding interval, and resorption.
    Young JF; Kadlubar FF
    Drug Metab Dispos; 1982; 10(6):641-4. PubMed ID: 6130914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.